MARATTO

article · Future Medicinal Chemistry

Design, synthesis, in silico, and biological evaluation of novel pyrazolopyrimidinone-based estrogen receptor inhibitors

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

Compounds <b>5a</b> and <b>5b</b> showed remarkable activity toward tumors which have higher estrogen expression.

Research topics

  • Estrogen and related hormone effects
  • Synthesis and biological activity
  • Computational Drug Discovery Methods

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/17568919.2026.2642673

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.